MARCA |
CÓDIGO |
DESCRIÇÃO |
INFO. TÉCNICAS |
APRESENT. |
VALOR |
COTAÇÃO |
USP |
1237752 |
Eprinomectin (300 mg) (COLD SHIPMENT REQUIRED) |
|
|
- |
|
USP |
1013024 |
Allopurinol Related Compound A (25 mg) (3-Amino-4-carboxamidopyrazole Hemisulfate) |
|
|
- |
|
USP |
1044549 |
Atorvastatin Related Compound C (20 mg) (Calcium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyhepta |
|
|
- |
|
USP |
1075203 |
Bis(2-ethylhexyl)maleate (2 g) (Maleic acid, bis(2-ethylhexyl)ester) |
|
|
- |
|
USP |
1074073 |
Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
|
|
- |
|
USP |
1614670 |
Sodium Starch Glycolate Type B (400 mg) |
|
|
- |
|
USP |
1029909 |
Ammonio Methacrylate Copolymer Type A (500 mg) |
|
|
- |
|
USP |
1046067 |
Azithromycin Identity (75 mg) |
|
|
- |
|
USP |
1090717 |
Capecitabine Related Compound A (15 mg) (5'-deoxy-5-fluorocytidine) |
|
|
- |
|
USP |
1031514 |
Amoxicillin Related Compound A (15 mg) ((2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid) |
|
|
- |
|
USP |
1724827 |
Zoledronic Acid (150 mg) |
|
|
- |
|
USP |
1048630 |
Benazepril Related Compound B (15 mg) ((3S)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, |
|
|
- |
|
USP |
1048288 |
Beta Glucan (1 g) (Beta Glucan from Baker's Yeast (Saccharomyces cerevisiae) |
|
|
- |
|
USP |
1065709 |
Betaine Hydrochloride (200 mg) |
|
|
- |
|
USP |
1065618 |
Betahistine Hydrochloride (200 mg) |
|
|
- |
|
USP |
1043105 |
Ascorbyl Palmitate (500 mg) |
|
|
- |
|
USP |
1550001 |
Potassium Gluconate (200 mg) |
|
|
- |
|
USP |
1354309 |
Ivermectin (200 mg) |
|
|
- |
|
USP |
1354900 |
Kaempferol (15 mg) (3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one) |
|
|
- |
|
USP |
1298004 |
Gramicidin (200 mg) |
|
|
- |
|
USP |
1177000 |
Dexamethasone Phosphate (500 mg) |
|
|
- |
|
USP |
1301007 |
Guaifenesin (200 mg) |
|
|
- |
|
USP |
1557000 |
Prednisolone Sodium Phosphate (500 mg) |
- |
|
- |
|
USP |
1341001 |
Indomethacin (200 mg) |
|
|
- |
|
USP |
1286107 |
Formoterol Fumarate (200 mg) |
|
|
- |
|
USP |
1287766 |
Galantamine Hydrobromide Racemic (15 mg) |
|
|
- |
|
USP |
1288500 |
Gemfibrozil (200 mg) |
|
|
- |
|
USP |
1349025 |
Isoflurane Related Compound B (0.1 mL) (2,2,2-trifluoroethyldifluoromethyl ether) |
|
|
- |
|
USP |
1295527 |
Glyburide Related Compound B (25 mg) (methyl-[[4-[2-[(5-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate) (AS) |
|
|
- |
|
USP |
1272929 |
Fludeoxyglucose Related Compound B (10 mg) (2-chloro-2-deoxy-D-glucose) |
|
|
- |
|
USP |
1147009 |
Colistimethate Sodium (200 mg) |
|
|
- |
|
USP |
1141024 |
Clotrimazole Related Compound A (25 mg) ((o-chlorophenyl)diphenylmethanol) |
|
|
- |
|
USP |
1502009 |
Penicillin G Benzathine (200 mg) |
|
|
- |
|
USP |
1504503 |
Penicillin V Potassium (200 mg) |
|
|
- |
|
USP |
1510889 |
Perindopril Erbumine (100 mg) |
|
|
- |
|
USP |
1562000 |
Primidone (200 mg) |
|
|
- |
|
USP |
1562011 |
Primidone Related Compound A (20 mg) (2-ethyl-2-phenylmalonamide) |
|
|
- |
|
USP |
1576708 |
Propylene Glycol (5 x 1 mL) |
|
|
- |
|
USP |
1482003 |
Oxandrolone CIII (50 mg) |
|
|
- |
|
USP |
1485125 |
Oxybutynin Related Compound B (20 mg) (Cyclohexyl Mandelic Acid Methyl Ester) |
|
|
- |
|
USP |
1491004 |
Oxytetracycline (200 mg) |
|
|
- |
|
USP |
1477808 |
Octyldodecanol (3 x 100 mg) |
|
|
- |
|
USP |
1478367 |
Olmesartan Medoxomil (100 mg) |
|
|
- |
|
USP |
1478436 |
Olopatadine Related Compound C (35 mg) ((11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid) |
|
|
- |
|
USP |
1478491 |
Omeprazole Related Compound F and G Mixture (25 mg) |
|
|
- |
|
USP |
1396310 |
Metformin Related Compound A (30 mg) (1-Cyanoguanidine) |
|
|
- |
|
USP |
1357067 |
Leflunomide Related Compound C (10 mg) (N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide) |
|
|
- |
|
USP |
1568506 |
L-Proline (200 mg) |
|
|
- |
|
USP |
1431556 |
Methyl Oleate (5 x 100 mg) |
|
|
- |
|
USP |
1362103 |
Levofloxacin (200 mg) |
|
|
- |
|
USP |
1362114 |
Levofloxacin Related Compound A (25 mg) ((S)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic |
|
|
- |
|
USP |
1362602 |
Levonorgestrel (125 mg) |
|
|
- |
|
USP |
1366002 |
Lidocaine (250 mg) |
|
|
- |
|
USP |
1463304 |
Nicotine Bitartrate Dihydrate (400 mg) |
|
|
- |
|
USP |
1123000 |
Chlorpheniramine Maleate (125 mg) |
|
|
- |
|
USP |
1443599 |
Midazolam CIV (300 mg) |
|
|
- |
|
USP |
1443806 |
Milbemycin Oxime (200 mg) |
|
|
- |
|
USP |
1377010 |
Meclizine Related Compound A (15 mg) (4-Chlorobenzhydrol) |
|
|
- |
|
USP |
1444279 |
Mirtazapine (350 mg) |
|
|
- |
|
USP |
1356858 |
Lamivudine Resolution Mixture B (10 mg) (This is a mixture of lamivudine (about 94%) and lamivudine diastereomer (about 6%)) |
|
|
- |
|
USP |
1349502 |
L-Isoleucine (200 mg) |
|
|
- |
|
USP |
1620220 |
Stavudine System Suitability Mixture (10 mg) |
|
|
- |
|
USP |
1444707 |
Mitomycin (50 mg) |
|
|
- |
|
USP |
1353102 |
Diluted Isosorbide Mononitrate (750 mg) |
|
|
- |
|
USP |
1446837 |
Montelukast for Peak Identification (20 mg) |
|
|
- |
|
USP |
1357001 |
L-Leucine (200 mg) |
|
|
- |
|
USP |
1614396 |
Sodium Metabisulfite (2 X 500 mg) |
|
|
- |
|
USP |
1372005 |
L-Lysine Hydrochloride (200 mg) |
|
|
- |
|
USP |
1370291 |
Loratadine Related Compound B (15 mg) (8-Chloro-11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine) |
|
|
- |
|
USP |
1370269 |
Loratadine Related Compound C (15 mg) (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one) |
|
|
- |
|
USP |
1642879 |
Tadalafil (200 mg) |
|
|
- |
|
USP |
1707855 |
Valacyclovir Related Compound C (10 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate hydrochloride) |
|
|
- |
|
USP |
1617408 |
Sotalol Hydrochloride (300 mg) |
|
|
- |
|
USP |
1623626 |
Sucralose (400 mg) |
|
|
- |
|
USP |
1612608 |
Silver Sulfadiazine (200 mg) |
|
|
- |
|
USP |
1643419 |
Telmisartan (200 mg) |
|
|
- |
|
USP |
1692505 |
Trimethoprim (300 mg) |
|
|
- |
|
USP |
1636005 |
Sulfasalazine (125 mg) |
|
|
- |
|
USP |
1698002 |
Tromethamine (125 mg) |
|
|
- |
|
USP |
1651009 |
Tetracycline Hydrochloride (200 mg) |
|
|
- |
|
USP |
1667520 |
Tinidazole (200 mg) |
|
|
- |
|
USP |
1663008 |
Thioridazine Hydrochloride (200 mg) |
|
|
- |
|
USP |
1138427 |
Clobetasol Propionate Related Compound A (50 mg) (9-alpha-fluoro-11-beta-hydroxy-16-beta-methyl-3-oxoandrosta-1,4-diene-17(R)-spiro-2'-[4'-chloro-5'-e |
|
|
- |
|
USP |
1572536 |
Propofol Related Compound A (25 mg) (3,3'-5,5'-tetraisopropyldiphenol) |
|
|
- |
|
USP |
1604621 |
Risedronate Related Compound A (20 mg) ([1-Hydroxy-2-(2-pyridinyl)ethylidene]bis(phosphonic acid), monohydrate) |
|
|
- |
|
USP |
1604869 |
Rivastigmine Related Compound A (15 mg) ((+)-Di-(p-toluoyl)-D-tartaric acid) |
|
|
- |
|
USP |
1413988 |
R-Methotrexate (5 mg) ((R)-2-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzamido)pentanedioic acid) |
|
|
- |
|
USP |
1598100 |
Ractopamine Hydrochloride (200 mg) |
|
|
- |
|
USP |
1724420 |
Ziprasidone Related Compound B (10 mg) (5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione) |
|
|
- |
|
USP |
1711009 |
Vanillin Melting Point Standard (1 g) (Approximately 82 degrees) |
|
|
- |
|
USP |
1003042 |
Acetaminophen Related Compound D (50 mg) (N-phenylacetamide) |
|
|
- |
|
USP |
1004001 |
Acetanilide Melting Point Standard (1g) (Approximately 114 degrees) |
|
|
- |
|
USP |
1173202 |
Desmopressin Acetate (2.01 mg) (COLD SHIPMENT REQUIRED) |
- |
|
- |
|
USP |
1548032 |
Polyvinyl Acetate (1 g) |
|
|
- |
|
USP |
1102805 |
Cephradine (300 mg) |
|
|
- |
|
USP |
1098399 |
Silicified Microcrystalline Cellulose (1 g) |
|
|
- |
|
USP |
1111001 |
Chlorhexidine (200 mg) |
|
|
- |
|
USP |
1151855 |
Curcumin (30 mg) |
|
|
- |
|
USP |
1154525 |
Cyclobenzaprine Related Compound B (10 mg) (3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine, hydrochloride) |
|
|
- |
|
USP |
1170000 |
Demeclocycline Hydrochloride (200 mg) (COLD SHIPMENT REQUIRED) |
|
|
- |
|